Barriers and motives of active drug users to undergo treatment for chronic HepatitisC: a qualitative - PowerPoint PPT Presentation

1 / 16
About This Presentation
Title:

Barriers and motives of active drug users to undergo treatment for chronic HepatitisC: a qualitative

Description:

Public Health Service of Amsterdam started the Amsterdam Cohort Studies (ACS) in ... to change one's life. Persuasive influence of other people who receive ... – PowerPoint PPT presentation

Number of Views:45
Avg rating:3.0/5.0
Slides: 17
Provided by: adb88
Category:

less

Transcript and Presenter's Notes

Title: Barriers and motives of active drug users to undergo treatment for chronic HepatitisC: a qualitative


1
Barriers and motives of active drug users to
undergo treatment for chronic Hepatitis-C a
qualitative research
  • M.S. Vonk MSc
  • Public Health Services, Amsterdam
  • 16 November 2009, Manchester
  • C.E.A. Lindenburg, M. Prins U. Davidovich

2
Background
  • High prevalence-rates of Hepatitis-C (HCV) in
    active drug users (DU) 49-79
  • Estimated number of infected DU in The
    Netherlands 12,000-37,000
  • Treatment is long and can cause severe
    side-effects
  • DU are a difficult group for this long, intense
    treatment
  • However, a lot of DU tested positive for HCV but
    refuse treatment

3
Background
  • Public Health Service of Amsterdam started the
    Amsterdam Cohort Studies (ACS) in 1985
  • Cohort of 500 DU are in active follow-up
  • DU visit every 6 months for bloodscreening and
    fill in questionnaires
  • The Public Health Service of Amsterdam provided
    HCV- screening for this group of DU
  • After, additional screening and treatment
    opportunities were provided (Dutch-C project)

4
Methods - Recruitment
5
Aims
  • Reasons to perform this research were
  • No scientific data about barriers and motives for
    treatment, directly obtained from DU
  • Feedback for improving the current program
  • Enhance motivational communication in recruitment
    campaigns
  • A basis for developing programs elsewhere
  • Aims of this research were, to explore
  • The barriers that served as a basis for refusal
    of treatment among DU
  • The motives for treatment acceptance among DU
  • The motives for treatment adherence and
    completion among DU

6
Methods
  • Qualitative design gain an in-depth
    understanding of human behaviour
  • Data-collection by in-depth semi-structured
    interviews (30-45 minutes)
  • Sample size based on saturation of data
  • Inclusion was based on accessibility and
    availability of the participants
  • Interviews recorded and transcribed
  • Participants received 12 euro for participation

7
Interviews analysis
  • Steps of analysis (based on Grounded Theory
    method)
  • Open coding (no pre-assigned codes)
  • Grouping open codes into groups with similar
    traits (categories)
  • Grouping categories in major themes
  • MaxQda was used for analyzing data
  • Health Belief model (Rosenstock, 1988) was used
    for interpretation of the results
  • Increased perceived susceptibility for, and
    severity of the disease will lead to positive
    treatment decision
  • Expectations about outcome of the disease
    (perceived costs, self-efficacy and perceived
    benefits) have an influence on treatment decision

8
Results
  • 22 participants were recruited for this study
  • 4 DU who refused treatment
  • 18 DU who accepted treatment
  • Barriers for treatment
  • Former barriers of DU who accepted treatment
  • Present barriers of DU who refused treatment
  • Motives for treatment
  • Reasons to continue treatment

9
Barriers for treatment
  • Fear of treatment side-effects
  • Wrong assumptions about the consequences of HCV
  • Lack of knowledge of HCV
  • Doubt about efficiency of therapy
  • Rejection by caregivers
  • Frustration concerning discrepancy in messages
    from different caregivers

Yes, I was a junky. Thats how they call me,
straight to my face. I was a druguser and a junky
and I didnt have any perseverance
Because I didnt notice anything about myself.
So they could have maybe found it or something,
but I didnt feel bad at all. And at this moment
I still dont feel bad
10
Motives for treatment
  • Avoidance of negative consequences related to HCV
  • Trust in organization or caregiver
  • Seeing treatment as opportunity to change ones
    life
  • Persuasive influence of other people who
    receive(d) treatment
  • Chance to feel better
  • Good cure prognosis
  • Care for the personal environment of the DU

If I dont follow treatment there will be a
reasonable possibility that I will be dead in few
years. And that idea strengthened my motivation
to follow therapy
This women was concerned about her pet It was
either the treatment or the dog and I wouldnt
want to go for that. The dog would be superior in
this case. Eventually help came, my friend said
Go, Ill take care of the dog.
And try to repair what can be repaired. For years
Ive only just ruined my body, so now I have to
try to repair what can be repaired
11
Reasons to continue treatment
  • Total committment to medical recommendation
  • Support
  • Good news about results of treatment
  • To do well in ones life

I liked coming here, to have a little
conversation. Make a joke with S. That had an
influence to continue treatment. I Find that an
advantage
My desire to do something good in my life. After
50 years I can finnally accomplish something
12
Conclusions
  • Reasons (barriers) differ strongly between
    individuals
  • To improve treatment enrolment
  • Increasing perceived susceptibility for, and
    severity of HCV among DU
  • Provide tailored information that targets each
    individual barrier
  • Generating and communicating positive peer
    opinion regarding participation in treatment.
  • The perceived high costs of treatment can be
    absorbed through offering extensive and ongoing
    personal support before and during treatment by
    caregivers

13
Acknowledgements
  • Dr. Udi Davidovich Public Health Services
    Amsterdam
  • Dr. Maria Prins Public Health Services Amsterdam
  • Dr. Claudia Gamel Utrecht University,
    department of Nursing Science
  • Dr. Christine Weegink Academic Medical Center,
    Amsterdam
  • Dr. Henk Reesink Academic Medical Center,
    Amsterdam
  • Drs. Karen Lindenburg Public Health Services
    Amsterdam

14
Qualitative Research
  • Qualitative research is characterized by
  • Demonstration of relevant concepts and themes
    related to
  • subject of research
  • Use of qualitative design
  • Undiscovered scientific area
  • Understand which concepts/ variables are
    experienced by the population under study
  • Insight in experiences of treatment or attitude
  • You dont want to demonstrate effect, but gain
    in-depth insight in human influence. Therefore
    you dont need to have a big sample.

15
Health Belief Model
16
Example of Analysis (coding)
  • Quote
  • I thought, well, if I will not do the therapy it
    will be a reasonable possibility that I will
  • be dead in a few years. And that idea
    strenghtened my motive to go for the therapy
  • Code knowledge of consequences HCV
  • Category Avoidance negative symptoms related to
    HCV
  • Concept Motive for treatment
Write a Comment
User Comments (0)
About PowerShow.com